---
title: "Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Long-term morbidity"
description: "Formulary evidence on Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Long-term morbidity. Topics: Health status in adulthood: mobility, scoliosis, epilepsy, and gastrointestinal problems; Scoliosis: progression to severe curves and spinal surgery; Gross motor decline in adolescence and adulthood; Bone health: low bone mass and fractures; 3 further topics. 7 evidence topics quoted from 9 sources."
canonical: "https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description/long-term-morbidity"
published: "2026-11-15T20:23:41-05:00"
modified: "2026-11-15T20:23:41-05:00"
---

# Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Long-term morbidity

<a id="heading-2.2.1.7"></a>

## 2.2.1.7 Long-term Morbidity

<a id="topic-2.2.1.7-1"></a>

### Health status in adulthood: mobility, scoliosis, epilepsy, and gastrointestinal problems

> “The median age of the combined cross-sectional cohort was 25 years (range 18 to 54 years), the majority (71%) were living in their parental home and the remainder being cared for in group homes or other institutions. Just over half walked either independently (18%) or with assistance (43%). The majority (86%) had scoliosis with 40% of those having undergone corrective surgery. Almost two-thirds (64%) of the women were taking anti-epileptic medications at the time of data collection. Constipation was highly prevalent (83%) and many experienced bloating (53%).”
> “Sleep disturbance was relatively common (63%), and adverse mood events and anxiety were slightly more prevalent in those aged 26-30 years in comparison to the younger and older age groups. Other frequently reported medical conditions included urinary tract infections, pneumonia and other respiratory conditions.”

Source: [Anderson et al. (2014)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4078387/)

<a id="topic-2.2.1.7-2"></a>

### Scoliosis: progression to severe curves and spinal surgery

> “913 females with classic RTT were included. Scoliosis frequency and severity increased with age. Severe scoliosis was found in 251 participants (27%), 113 of whom developed severe scoliosis during the follow-up assessments. 168 (18%) had surgical correction.”
> “In terms of the actual age distribution for the 168 participants who had surgical correction, the majority (86%) occurred between age 9 and 15, the median age was 12 years (min=5, max=21).”

Source: [Killian et al. (2017)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5461984/)

> “All 30 women had scoliosis that progressed slowly throughout their lives, but only one was reported as having undergone surgery.”

Source: [Hryniewiecka-Jaworska et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11975466/)

<a id="topic-2.2.1.7-3"></a>

### Gross motor decline in adolescence and adulthood

> “here we demonstrate that slow loss of gross motor skills occurs during Stage III.”

Source: [Neul et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13094048/)

> “The study included 24 individuals aged 30-66 years at last visit after a follow-up period of 6-12 years. Results showed a clinically observable and significant decline in gross motor skills using the Rett syndrome Gross Motor Scale (RSGMS) with a tendency of less decline in the individuals with the best motor abilities.”
> “Decline in RSGMS score was associated with the presence of epilepsy and severe scoliosis that had been conservatively managed.”

Source: [Bisgaard et al. (2021)](https://pubmed.ncbi.nlm.nih.gov/34296518/)

> “Of those 26 women walking after their childhood regression, two (8%) permanently lost their ability to walk in their 20s and nine (37.5%) of those still walking in their 40s lost that ability during their 40s or 50s.”

Source: [Hryniewiecka-Jaworska et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11975466/)

<a id="topic-2.2.1.7-4"></a>

### Bone health: low bone mass and fractures

> “however individuals as young as three and four years of age had low BMC and aBMD values in the lumbar spine”
> “The fracture incidence in an Australian RTT population was shown to be 43.3 per 1000 person years, which equates to a rate nearly four times that of the general population”

Source: [Jefferson et al. (2016)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4743907/)

<a id="topic-2.2.1.7-5"></a>

### Respiratory complications: aspiration, lower respiratory tract infection, and respiratory failure

> “Of the 1,994 with RTT, 7.27% (n = 145), 9.48% (n = 189), and 10.08% (n = 201) experienced post-index aspiration, LRTI, and RF, respectively.”

Source: [Rajagopalan et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12580911/)

> “Of eligible individuals, 25 (28.1%) were aspiration cases. The cumulative rate of RF among RTT individuals with and without aspiration was 60.0% and 6.3%, respectively.”
> “Aspiration cases were more likely to have LRTI (50% vs. 5.0%) and ≥ 1 inpatient admissions than non-aspiration controls (75.0% vs. 35.0%) (all p < 0.05).”

Source: [Rashid et al. (2025a)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12082938/)

<a id="topic-2.2.1.7-6"></a>

### Epilepsy: course across the lifespan

> “Three distinct patterns of seizure prevalence emerged in classic Rett syndrome, including those who did not have seizures throughout the study, those who had frequent relapse and remission, and those who had relentless seizures. Although 248 of those with classic Rett syndrome and a history of seizures were in terminal remission at last contact, only 74 (12% of those with a history of epilepsy) were seizure free and off anti-seizure medication.”

Source: [Tarquinio et al. (2017)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5278305/)

> “Seizures were reported for 18 of 30 women (60%) at some stage during their lives. Ten (33%) had epileptic seizures in middle age, usually generalised tonic–clonic (GTC) or myoclonic seizures, with the seizures being well controlled on medication in nine.”

Source: [Hryniewiecka-Jaworska et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11975466/)

<a id="topic-2.2.1.7-7"></a>

### Mood in middle age: unexplained sadness

> “Twenty‐five women (83%) had episodes of unexplained sadness at some point in their lives. Nine women (30%) had unexplained weight loss during adulthood.”

Source: [Hryniewiecka-Jaworska et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11975466/)

## Related pages
- [Lonimecgene renparvovec (TSHA-102): Rett syndrome](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Terms and abbreviations](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/terms-and-abbreviations.md)
- [Lonimecgene renparvovec (TSHA-102): Rett syndrome](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/executive-summary) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/executive-summary.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Product information and disease description](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Clinical evidence](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/clinical-evidence.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Economic information and modeling report](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/economics) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/economics.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: References](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/references) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/references.md)
